A Window-of-opportunity Study of Pelareorep in Early Breast Cancer
Clinical trial NCT04102618 · TERMINATED
Trial details
- NCT number
- NCT04102618
- Sponsor
- Oncolytics Biotech
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2022-04-20
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.